The rationale for antimitotic treatment prior to bone marrow transplantation.
D000818:Animals; D016026:Bone Marrow Transplantation; D002463:Cell Membrane Permeability / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D006918:Hydroxyurea / Q000494:pharmacology*; D008214:Lymphocytes / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008938:Mitosis / Q000187:drug effects*; D011292:Premedication
D006918:Hydroxyurea